Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients

Published:2024 Issue: Volume:22 Page:100474
ISSN:2213-0489
Container-title:Leukemia Research Reports
language:en
Short-container-title:Leukemia Research Reports

Author:

Baron Jeffrey^ORCID,Pandey Manu R.,Griffiths Elizabeth A.,Wang Eunice S.

Publisher

Elsevier BV

Reference16 articles.

1. Why don't Jehovah's witnesses accept blood transfusions? April 24, 2024, 2024. https://www.jw.org/en/jehovahs-witnesses/faq/jehovahs-witnesses-why-no-blood-transfusions/.

2. Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's witnesses;Muramoto;BMJ,2001

3. Haddad F.G., Sawyers J., Short N.J. Treatment de-escalation in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens. Ther. Adv. Hematol. 2023;14:20406207231151294. doi:10.1177/20406207231151294.

4. A phase II study of Dasatinib and Dexamethasone as primary therapy followed by transplantation for adults with newly diagnosed Ph/BCR-ABL1-positive acute lymphoblastic leukemia (Ph+ ALL): final results of alliance/CALGB study 10701;Wieduwilt;Blood,2018

5. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia;Foa;Blood,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3